Title : Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis.

Pub. Date : 2010 Jul

PMID : 20540652






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Clinical effectiveness and safety evaluation of long-term pioglitazone treatment for erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis. Pioglitazone erythropoietin Homo sapiens
2 BACKGROUND: We aimed to assess the effect of long-term pioglitazone treatment on erythropoietin responsiveness and insulin resistance in type 2 diabetic patients on hemodialysis. Pioglitazone erythropoietin Homo sapiens
3 RESULTS: Pioglitazone effectively reduced erythropoietin dose and maintained the target hemoglobin levels by improving insulin resistance up to the end of the study. Pioglitazone erythropoietin Homo sapiens
4 Erythropoietin responsiveness improved with a reduction in erythropoietin dose and may be associated with the improvement in insulin resistance due to long-term pioglitazone treatment. Pioglitazone erythropoietin Homo sapiens